Eli Lilly and Company Eli Lilly and Company Files Form 8K

Eli Lilly and Company: Eli Lilly and Company Files Form 8-K

09:54 EST 6 Nov 2018 | EQS Group

Eli Lilly and Company
Eli Lilly and Company: Eli Lilly and Company Files Form 8-K

06-Nov-2018 / 14:54 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


ELI LILLY AND COMPANY FILES A FORM 8-K

INDIANAPOLIS, November 6, 2018 -Eli Lilly and Company (NYSE / Euronext Paris / SIX: LLY)today informs its shareholders that it has filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission ("SEC") on November 6, 2018, announcing financial results for the third quarter of 2018.

Lillmakes available free of charge on its website, its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, reports filed pursuant to Section 16 of the U.S. Securities Exchange Act of 1934 and amendments to those reports filed with or furnished to the SEC as soon as reasonably practicable after Lillelectronically files these documents with, or furnishes them to, the SEC.These documents are posted on Lilly's website at www.lilly.com- under "Investors."

The SEC maintains a website that contains reports, proxy statements and other information regarding issuers that file electronically with the SEC. These materials may be obtained electronically by accessing the SEC's home page at www.sec.gov.

Copies of the above referenced information will also be made available, free of charge, upon written request to the Company's secretary atLilly Corporate Center, Indianapolis, Indiana 46285, U.S.A.


Regulatory filing PDF file

Document title: Eli Lilly and Company Files Form 8-K
Document: http://n.eqs.com/c/fncls.ssp?u=NXDWYMLRSO

show this

Original Article: Eli Lilly and Company: Eli Lilly and Company Files Form 8-K

More From BioPortfolio on "Eli Lilly and Company: Eli Lilly and Company Files Form 8-K"